Cargando…

Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer

Breast cancer is a remarkably complex and diverse disease. Subtyping based on morphology, genomics, biomarkers and/or clinical parameters seeks to stratify optimal approaches for management, but it is clear that every breast cancer is fundamentally unique. Intra-tumour heterogeneity adds further com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutasovic, Jamie R., McCart Reed, Amy E., Sokolova, Anna, Lakhani, Sunil R., Simpson, Peter T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226487/ https://www.ncbi.nlm.nih.gov/pubmed/32244556 http://dx.doi.org/10.3390/cancers12040848

Ejemplares similares

Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
por: Reed, Amy E McCart, et al.
Publicado: (2015)

Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related
por: Kutasovic, Jamie R., et al.
Publicado: (2020)

The Genomic Landscape of Lobular Breast Cancer
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950
por: McCart Reed, Amy E., et al.
Publicado: (2021)

A Molecular and Morphological Deep-Dive Into Metaplastic Breast Cancers
por: McCart Reed, Amy E, et al.
Publicado: (2019)

Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Metastatic progression of breast cancer: insights from 50 years of autopsies
por: Cummings, Margaret C, et al.
Publicado: (2014)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

An Update on the Molecular Pathology of Metaplastic Breast Cancer
por: McCart Reed, Amy E, et al.
Publicado: (2021)

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020)

Editorial: Molecular mechanisms in breast cancer progression and metastasis
por: Fedele, Monica, et al.
Publicado: (2022)

NDRG1 in Cancer: A Suppressor, Promoter, or Both?
por: Joshi, Vaibhavi, et al.
Publicado: (2022)

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016)

Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms
por: Feng, Yufan, et al.
Publicado: (2023)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
por: Kalaw, Emarene, et al.
Publicado: (2020)

Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer—insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system
por: Wafai, Razan, et al.
Publicado: (2020)

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
por: Kutasovic, Jamie R, et al.
Publicado: (2018)

Using whole-genome sequencing data to derive the homologous recombination deficiency scores
por: de Luca, Xavier M., et al.
Publicado: (2020)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

LobSig is a multigene predictor of outcome in invasive lobular carcinoma
por: McCart Reed, Amy E., et al.
Publicado: (2019)

Toothache of Horses
por: McCart, T. S.
Publicado: (1887)

The pathology of familial breast cancer: Morphological aspects
por: Lakhani, Sunil R
Publicado: (1999)

Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development
por: Kondrashova, Olga, et al.
Publicado: (2021)

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
por: Saunus, Jodi M., et al.
Publicado: (2022)

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
por: Croft, Priyakshi Kalita-de, et al.
Publicado: (2021)

Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer
por: Abdel-Fatah, Tarek M. A., et al.
Publicado: (2020)

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer
por: Milevskiy, Michael J.G., et al.
Publicado: (2016)

Expressive dynamics models with nonlinear injective readouts enable reliable recovery of latent features from neural activity
por: Versteeg, Christopher, et al.
Publicado: (2023)

Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling
por: Mungunsukh, Ognoon, et al.
Publicado: (2014)

Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients
por: Visan, Kekoolani S., et al.
Publicado: (2022)

Molecular Aspects of Breast Cancer Metastasis to the Brain
por: Saunus, Jodi M., et al.
Publicado: (2011)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

The Pathology of Hereditary Breast Cancer
por: Lakhani, Sunil R.
Publicado: (1999)

N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease
por: Shewell, Lucy K., et al.
Publicado: (2022)

Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
por: Nones, K, et al.
Publicado: (2019)

The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cr04judv8a7ar54dgj1lp7gqtm